ACE and diabetes mellitus: Previous data captured in the National Pregnancy in Diabetes Audit (NPID) 2020–2022 report a prescription rate of 4% for statins, 4% for ACE inhibitors, and 7% for adverse diabetes medications in women with type 2 diabetes who became pregnant.16